Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

DongA Science
dongascience.com > en > news > 79816

Insilico Medicine’s AI-designed IPF drug slows biological aging in trial

5+ day, 5+ hour ago   (542+ words) Early clinical trial results suggest that a lung disease treatment designed with artificial intelligence (AI) may lower patients’ biological age. The findings indicate that an AI-designed drug candidate might also help slow aging. IPF is a chronic disease in which…...